NR1H4 and metabolic disease: Since BAs have a major impact on the host metabolism and immune function through farnesoid X receptor (FXR) and membrane-associated GPCR5 signaling, gut dysbiosis or BA imbalance may contribute to the development of metabolic diseases [79,80].